Asparaginase Erwinia chrysanthemi
|Generic name||Asparaginase Erwinia chrysanthemi|
|Pronunciation||as-PAYR-uh-jih-NAYS er-WIH-nee-uh krih-SAN-theh-my|
|Brand name(s), other common name(s)||ErwinazeTM|
|Drug type||Enzyme that prevents cancer cells from surviving|
|How the drug is given||Intramuscular (IM) injection|
Asparaginase Erwinia chrysanthemi is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.
Side effects needing medical attention:Serious allergic reactions (tightness in throat, abnormal swelling/redness or difficulty breathing), some of which may be life-threatening; inflammation of the pancreatitis (stomach pain); abnormal blood clotting (may have headache, pain in leg, arm, or chest); unusual bleeding; liver problems; nausea, vomiting, and abnormal blood sugar levels (may be thirsty or frequently urinate).